• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 2007

View Archived Issues

Takeda reports first half ended September 30, 2007 results

Read More

DOR BioPharma enters cooperative agreement for RiVax with Walter Reed Army Institute

Read More

PhotoCure to de-merge its cancer-focused drug delivery subsidiary PCI Biotech

Read More

Phase III clinical study of ALK-Abello's grass pollen vaccine fails to meet primary endpoint

Read More

Peregrine receives approval in Georgia to initiate phase II trial of bavituximab

Read More

European Commission endorses positive opinion of EMEA for sanofi-aventis' Acomplia

Read More

EMEA grants orphan drug status to Vx-001 for non-small cell lung cancer

Read More

Celgene acquires Pharmion

Read More

Quark initiates phase I clinical trial of AKIi-5 for acute renal failure

Read More

BioXell initiates phase IIa trial of elocalcitol for male infertility

Read More

Takeda establishes Takeda San Francisco for therapeutic antibody research

Read More

KCNQ2/3 channel opener from ICAgen shows activity in pain in vivo models

Read More

NIAID sponsors phase I trial of Avant's E. coli-cholera vaccine Peru-15 pCTB

Read More

Small peptide inhibitor of PKC gamma shows activity in neuropathic pain models

Read More

Inflazyme sells majority of its research and development assets to Biolipox

Read More

Novel therapeutic agents for respiratory and allergic disorders described in recent patents

Read More

Recent Novartis patent discloses novel agents for renal failure

Read More

Studies describe novel non-nucleoside HCV RNA polymerase inhibitor GS-9190

Read More

Benefits of ranolazine treatment seen in MERLIN-TIMI 36 trial

Read More

AZD-9056 studied in healthy volunteers and rheumatoid arthritis patients

Read More

AMG-108 not significantly effective in knee osteoarthritis patients

Read More

Targeted Genetics releases findings from study of tgAAC94 in inflammatory arthritis

Read More

Actelion patents novel dual orexin OX1/OX2 receptor antagonists for eating disorders

Read More

Marketing and sale of Novartis' Prexige suspended in U.K. and Germany

Read More

FDA approves supplemental NDA for Avalide for hypertension

Read More

Chugai and Roche file FDA BLA for Actemra in RA indication

Read More

CHMP recommends Merck, Sharp and Dohme's Ivemend for nausea with chemotherapy

Read More

Abilify receives FDA approval for adjunctive treatment of MDD

Read More

MSD's Isentress for HIV-1 infection gets positive opinion from CHMP

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 27, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 27, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 24, 2025
  • BIO2025: John Crowley and Martin Makary

    BIO 2025: Makary lays out FDA’s path, launches pilot review program

    BioWorld
    On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...
  • Andembry

    New orphan drug, CSL’s garadacimab, cleared for hereditary angioedema

    BioWorld
    Following a complete response letter issued last October over CMC issues, CSL Behring LLC gained U.S. FDA approval June 16 of its humanized anti-factor XIIa...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe